Engineering the Therapeutic Window in HER2 Radioligand Therapy: First-in-Human Experience with Affibody molecule ABY-271

Name: Engineering the Therapeutic Window in HER2 Radioligand Therapy: First-in-Human Experience with Affibody molecule ABY-271
Start: 2026-12-03T14:00
Location: Renaissance London Heathrow Hotel

Targeted Radiopharmaceuticals Summit EU 2026 · 3 December 2026 · 14:00

Engineering the Therapeutic Window in HER2 Radioligand Therapy: First-in-Human Experience with Affibody molecule ABY-271 was a session at Targeted Radiopharmaceuticals Summit EU 2026 on 3 December 2026 in London, with 1 speaker on record.

Speakers

Guido Würth — Speaker Head of Corporate Development & Radiopharma Medical & Health; Sales; Operations, Affibody AB